Optimizing Enteral Nutrition in Acute Care

Evidence-Based Strategic Insights on Post-Discharge Transitions, Formula Selection & Brand Switching Behavior

Market Research180 Clinicians and StakeholdersU.S., Germany, and Japan

Understand real-world enteral nutrition decisions and continuity across acute, post-acute, and home care

Study Type

Market Research

Positioning

Understand real-world enteral nutrition decisions and continuity across acute, post-acute, and home care

Sample Size

180 dietitians, physicians & nurses

Markets

U.S., Germany, and Japan

Respondent Type

Clinicians & decision-makers in enteral tube feeding management

Why We Conducted This Study

Enteral tube feeding management extends well beyond inpatient hospital stays, with discharge and post-acute care shaping long-term product continuity and outcomes. However, the real-world insights into switching behavior and points of transitions in post-acute settings are limited.

This study assesses post-discharge care setting, formula and brand selection, switching behavior, and decision drivers across stroke, head and neck cancer, and gastrointestinal (GI) disorders, providing actionable intelligence for manufacturers and commercial teams operating across the full care continuum.

Research Methodology

Study DesignCross-sectional survey; quantitative and structured.
Sample180 qualified clinicians responsible for enteral feeding decisions
GeographiesU.S., Germany, and Japan.
Focus AreaStroke, Head & Neck Cancer, and gastrointestinal (GI) disorders
Analytical ApproachQuantitative and perception-based analysis capturing transition-of-care practices, brand patterns, and switching drivers.

Brands Covered in This Study

Nestlé Health Science
Abbott Nutrition
Nutricia / Danone
Fresenius Kabi
Kate Farms
Real Food Blends
B. Braun
Otsuka
Morinaga / Clinico
HiPP
Meiji
Simplee Foods

What the Study Delivers

1

Discharge as inflection point

Post-discharge patient volumes substantially exceed inpatient volumes across all three conditions, reinforcing the importance of transition-of-care decisions for product continuity.

2

Home care channel dominance

Post-discharge management is primarily home based (67.6-85.9% across conditions), making home caregivers and home health services key levers for education and adherence.

3

Formula selection at discharge

Standard/complete formulas account for ~41% of discharge prescriptions; specialized, organic, and plant-based formulas each capture less than 15%, with slightly higher customization observed among GI patients.

4

Partial vs. exclusive feeding

Partial tube feeding is the dominant mode (~46-53% across conditions), supporting portfolio opportunities for supplementation and step-up/step-down regimens.

5

Competitive landscape

Nestlé Health Science leads post-discharge prescribing (~23% aggregate share); Abbott Nutrition and Nutricia/Danone form a strong secondary tier; together with Fresenius Kabi, the top four brands account for most discharge prescriptions. Kate Farms and Real Food Blends lead overall satisfaction scores despite holding limited discharge share.

6

Brand awareness benchmarked

Nestlé Health Science (4.30), Abbott Nutrition (4.44), Nutricia/Danone (4.17), and Fresenius Kabi (4.13) demonstrate the strongest recognition across the broadest respondent base. Otsuka and Morinaga/Clinico show very high awareness among Japanese respondents specifically. Mid-tier brands — B. Braun, Kate Farms, Real Food Blends — show moderate awareness with upside potential.

7

Brand continuity risk

Brand-specific prescribing is common (~74-81%), but inpatient-to-discharge brand changes occur frequently — stroke: 60%; head and neck cancer: 50%; GI: 40%.

8

Tolerability as primary driver

Tolerability toward a specific manufacturer portfolio is the most important factor influencing brand selection at discharge (importance score: 4.00, High tier) and the leading trigger for early switching at approximately one month — outweighing cost, peer influence, and formulary factors.

9

Satisfaction gaps by brand

Kate Farms and Real Food Blends lead overall satisfaction (5.67 and 5.62, respectively). Abbott Nutrition and Nestlé Health Science score highest on brand reputation and product options. Insurance coverage and manufacturer support are the weakest attributes across all brands, including Fresenius Kabi, Morinaga/Clinico, and Otsuka.

10

Stakeholder influence mapping

Physicians and dietitians hold the highest reported involvement in formula brand selection; facility managers contribute meaningfully in facility-based transitions; pharmacists report the lowest involvement across all brands and settings.

Who This Research Is Built For

Enteral nutrition & medical food manufacturers
Commercial strategy & market access teams
Medical affairs & clinical development leaders
Supportive care & nutrition strategy teams
Portfolio, innovation & lifecycle management teams

Access the Full Research

Fill the form to access full research

Our Locations

Massachusetts, USA
75 State Street, Ste 100,
Boston, Massachusetts, 02109, USA

Dusseldorf, Germany
Ground floor, Kaiserswerther Strasse 135
Dusseldorf, 40474, Germany

New Tehri, India
2G-34, Vidhi Vihar, New Tehri,
Tehri Gharwal, Uttarakhand - 249001, India

Ohio, USA
2435 E Gill Road,
Port Clinton OH 43452, USA

New South Wales, Australia
1 Denison St, North Sydney
New South Wales, 2060, Australia

Dehradun, India
1st floor, RR tower, Kargi Chowk,
Dehradun, Uttrakhand - 248001 India

© 2026 TehriHills Consulting. All rights reserved.